{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:15:31Z","timestamp":1793121331146,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00405-013-2786-4","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T06:49:25Z","timestamp":1382942965000},"page":"2931-2936","source":"Crossref","is-referenced-by-count":92,"title":["Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial"],"prefix":"10.1007","volume":"271","author":[{"given":"Anjali","family":"Lepcha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Amalanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Mary","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achamma","family":"Balraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,29]]},"reference":[{"key":"2786_CR1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.56.4.436","volume":"56","author":"H Neuhauser","year":"2001","unstructured":"Neuhauser H, Leopold M, von Brevern M et al (2001) The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 56:436\u2013441","journal-title":"Neurology"},{"key":"2786_CR2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s004150050478","volume":"246","author":"M Dieterich","year":"1999","unstructured":"Dieterich M, Brandt T (1999) Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 246:883\u2013892","journal-title":"J Neurol"},{"key":"2786_CR3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1526-4610.1992.hed3206300.x","volume":"32","author":"FM Cutrer","year":"1992","unstructured":"Cutrer FM, Baloh RW (1992) Migraine-associated Dizziness. Headache J Head Face Pain 32:300\u2013304. doi: 10.1111\/j.1526-4610.1992.hed3206300.x","journal-title":"Headache J Head Face Pain"},{"key":"2786_CR4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/000348949710600302","volume":"106","author":"SP Cass","year":"1997","unstructured":"Cass SP, Furman JM, Ankerstjerne JKP et al (1997) Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol 106:182\u2013189","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2786_CR5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/jnnp.42.4.363","volume":"42","author":"R Slater","year":"1979","unstructured":"Slater R (1979) Benign recurrent vertigo. J Neurol Neurosurg Psychiatry 42:363\u2013367","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2786_CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.1294","volume":"100","author":"AK Oh","year":"2001","unstructured":"Oh AK, Lee H, Jen JC et al (2001) Familial benign recurrent vertigo. Am J Med Genet 100:287\u2013291","journal-title":"Am J Med Genet"},{"key":"2786_CR7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629\u2013808. doi: 10.1177\/0333102413485658","journal-title":"Cephalalgia"},{"key":"2786_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/VES-2012-0453","volume":"22","author":"T Lempert","year":"2012","unstructured":"Lempert T, Olesen J, Furman J et al (2012) Vestibular migraine: diagnostic criteria. J Vestib Res 22:167\u2013172. doi: 10.3233\/VES-2012-0453","journal-title":"J Vestib Res"},{"key":"2786_CR9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00415-009-5050-5","volume":"256","author":"M Fotuhi","year":"2009","unstructured":"Fotuhi M, Glaun B, Quan SY, Sofare T (2009) Vestibular migraine: a critical review of treatment trials. J Neurol 256:711\u2013716. doi: 10.1007\/s00415-009-5050-5","journal-title":"J Neurol"},{"key":"2786_CR10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1212\/01.WNL.0000049476.40047.A3","volume":"60","author":"H Neuhauser","year":"2003","unstructured":"Neuhauser H, Radtke A, von Brevern M, Lempert T (2003) Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology 60:882\u2013883","journal-title":"Neurology"},{"issue":"Suppl 8","key":"2786_CR11","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00005344-199118081-00008","volume":"18","author":"R Schmidt","year":"1991","unstructured":"Schmidt R, Oestreich W (1991) Flunarizine in migraine prophylaxis: the clinical experience. J Cardiovasc Pharmacol 18(Suppl 8):S21\u2013S26","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 8","key":"2786_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/03331024880080S804","volume":"8","author":"JM Mart\u00ednez-Lage","year":"1988","unstructured":"Mart\u00ednez-Lage JM (1988) Flunarizine (Sibelium) in the prophylaxis of migraine. An open, long-term, multicenter trial. Cephalalgia Int J Headache 8(Suppl 8):15\u201320","journal-title":"Cephalalgia Int J Headache"},{"key":"2786_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpn.2012.10.001","volume":"17","author":"H Kim","year":"2013","unstructured":"Kim H, Byun SH, Kim JS et al (2013) Comparison of flunarizine and topiramate for the prophylaxis of pediatric migraines. Eur J Paediatr Neurol 17:45\u201349. doi: 10.1016\/j.ejpn.2012.10.001","journal-title":"Eur J Paediatr Neurol"},{"key":"2786_CR14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1468-2982.2002.t01-1-00309.x","volume":"22","author":"HC Diener","year":"2002","unstructured":"Diener HC, Matias-Guiu J, Hartung E et al (2002) Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160\u00a0mg daily. Cephalalgia Int J Headache 22:209\u2013221","journal-title":"Cephalalgia Int J Headache"},{"key":"2786_CR15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1017\/S0317167100041962","volume":"19","author":"MJ Gawel","year":"1992","unstructured":"Gawel MJ, Kreeft J, Nelson RF et al (1992) Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine. Can J Neurol Sci 19:340\u2013345","journal-title":"Can J Neurol Sci"},{"key":"2786_CR16","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/mds.23191","volume":"25","author":"KC Simon","year":"2010","unstructured":"Simon KC, Gao X, Chen H et al (2010) Calcium channel blocker use and risk of Parkinson\u2019s disease. Mov Disord 25:1818\u20131822. doi: 10.1002\/mds.23191","journal-title":"Mov Disord"},{"key":"2786_CR17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.parkreldis.2006.08.011","volume":"13","author":"TGN Ton","year":"2007","unstructured":"Ton TGN, Heckbert SR, Longstreth WT Jr et al (2007) Calcium channel blockers and beta-blockers in relation to Parkinson\u2019s disease. Parkinsonism Relat Disord 13:165\u2013169. doi: 10.1016\/j.parkreldis.2006.08.011","journal-title":"Parkinsonism Relat Disord"},{"key":"2786_CR18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1468-2982.1998.1806349.x","volume":"18","author":"C Lucetti","year":"1998","unstructured":"Lucetti C, Nuti A, Pavese N et al (1998) Flunarizine in migraine prophylaxis: predictive factors for a positive response. Cephalalgia Int J Headache 18:349\u2013352","journal-title":"Cephalalgia Int J Headache"},{"key":"2786_CR19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ncl.2008.11.004","volume":"27","author":"H Neuhauser","year":"2009","unstructured":"Neuhauser H, Lempert T (2009) Vestibular migraine. Neurol Clin 27:379\u2013391. doi: 10.1016\/j.ncl.2008.11.004","journal-title":"Neurol Clin"},{"key":"2786_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005537-199801001-00001","volume":"108","author":"GD Johnson","year":"1998","unstructured":"Johnson GD (1998) Medical management of migraine-related dizziness and vertigo. Laryngoscope 108:1\u201328","journal-title":"Laryngoscope"},{"key":"2786_CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1468-2982.1990.1004167.x","volume":"10","author":"O Kolev","year":"1990","unstructured":"Kolev O (1990) How caloric vestibular irritation influences migraine attacks. Cephalalgia Int J Headache 10:167\u2013169","journal-title":"Cephalalgia Int J Headache"},{"key":"2786_CR22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000111783","volume":"13","author":"J Vitkovic","year":"2008","unstructured":"Vitkovic J, Paine M, Rance G (2008) Neuro-otological findings in patients with migraine- and nonmigraine-related dizziness. Audiol Neurootol 13:113\u2013122. doi: 10.1159\/000111783","journal-title":"Audiol Neurootol"},{"issue":"Suppl 1","key":"2786_CR23","first-page":"9","volume":"24","author":"The International Classification of Headache Disorders: 2nd edition","year":"2004","unstructured":"The International Classification of Headache Disorders: 2nd edition (2004) Cephalalgia Int J Headache 24(Suppl 1):9\u2013160","journal-title":"Cephalalgia Int J Headache"},{"key":"2786_CR24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1212\/WNL.46.2.458","volume":"46","author":"RW Baloh","year":"1996","unstructured":"Baloh RW, Foster CA, Yue Q, Nelson SF (1996) Familial migraine with vertigo and essential tremor. Neurology 46:458\u2013460","journal-title":"Neurology"},{"key":"2786_CR25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1177\/0333102412459572","volume":"32","author":"D Magis","year":"2012","unstructured":"Magis D, Boon E, Coppola G et al (2012) A novel CACNA1A mutation results in episodic ataxia with migrainous features without headache. Cephalalgia Int J Headache 32:1147\u20131149. doi: 10.1177\/0333102412459572","journal-title":"Cephalalgia Int J Headache"},{"key":"2786_CR26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jocn.2003.08.008","volume":"11","author":"J Waterston","year":"2004","unstructured":"Waterston J (2004) Chronic migrainous vertigo. J Clin Neurosci 11:384\u2013388. doi: 10.1016\/j.jocn.2003.08.008","journal-title":"J Clin Neurosci"},{"key":"2786_CR27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00129492-200205000-00024","volume":"23","author":"MD Reploeg","year":"2002","unstructured":"Reploeg MD, Goebel JA (2002) Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol 23:364\u2013371","journal-title":"Otol Neurotol"},{"key":"2786_CR28","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1097\/01.mlg.0000231302.77922.c5","volume":"116","author":"A Maione","year":"2006","unstructured":"Maione A (2006) Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope 116:1782\u20131786. doi: 10.1097\/01.mlg.0000231302.77922.c5","journal-title":"Laryngoscope"},{"key":"2786_CR29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/wnf.0b013e31803bb3ee","volume":"30","author":"A Celiker","year":"2007","unstructured":"Celiker A, Bir LS, Ardi\u00e7 N (2007) Effects of valproate on vestibular symptoms and electronystagmographic findings in migraine patients. Clin Neuropharmacol 30:213\u2013217. doi: 10.1097\/wnf.0b013e31803bb3ee","journal-title":"Clin Neuropharmacol"},{"key":"2786_CR30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1756285611401647","volume":"4","author":"AR Bisdorff","year":"2011","unstructured":"Bisdorff AR (2011) Management of vestibular migraine. Ther Adv Neurol Disord 4:183\u2013191. doi: 10.1177\/1756285611401647","journal-title":"Ther Adv Neurol Disord"},{"key":"2786_CR31","first-page":"208","volume":"26","author":"C Della Pepa","year":"2006","unstructured":"Della Pepa C, Guidetti G, Eandi M (2006) Betahistine in the treatment of vertiginous syndromes: a meta-analysis. Acta Otorhinolaryngol Ital 26:208\u2013215","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"2786_CR32","first-page":"81","volume":"11","author":"KR Gottshall","year":"2005","unstructured":"Gottshall KR, Moore RJ, Hoffer ME (2005) Vestibular rehabilitation for migraine-associated dizziness. Int Tinnitus J 11:81\u201384","journal-title":"Int Tinnitus J"},{"issue":"Suppl 2","key":"2786_CR33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000117189","volume":"30","author":"J Olesen","year":"1990","unstructured":"Olesen J (1990) Calcium antagonists in migraine and vertigo. Possible mechanisms of action and review of clinical trials. Eur Neurol 30(Suppl 2):31\u201334 discussion 39\u201341","journal-title":"Eur Neurol"},{"issue":"Suppl 8","key":"2786_CR34","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00005344-199118081-00009","volume":"18","author":"R Schmidt","year":"1991","unstructured":"Schmidt R, Oestreich W (1991) Flunarizine in the treatment of vestibular vertigo: experimental and clinical data. J Cardiovasc Pharmacol 18(Suppl 8):S27\u2013S30","journal-title":"J Cardiovasc Pharmacol"},{"key":"2786_CR35","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00129492-200211000-00020","volume":"23","author":"J Corvera","year":"2002","unstructured":"Corvera J, Corvera-Behar G, Lapilover V, Ysunza A (2002) Objective evaluation of the effect of flunarizine on vestibular neuritis. Otol Neurotol 23:933\u2013937","journal-title":"Otol Neurotol"},{"key":"2786_CR36","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1586\/ern.12.104","volume":"12","author":"I Toldo","year":"2012","unstructured":"Toldo I, De Carlo D, Bolzonella B et al (2012) The pharmacological treatment of migraine in children and adolescents: an overview. Expert Rev Neurother 12:1133\u20131142. doi: 10.1586\/ern.12.104","journal-title":"Expert Rev Neurother"},{"key":"2786_CR37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11940-008-0003-3","volume":"10","author":"M Sch\u00fcrks","year":"2008","unstructured":"Sch\u00fcrks M, Diener H-C, Goadsby P (2008) Update on the prophylaxis of migraine. Curr Treat Options Neurol 10:20\u201329","journal-title":"Curr Treat Options Neurol"},{"key":"2786_CR38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1469-8749.2011.04154.x","volume":"54","author":"B Peer Mohamed","year":"2012","unstructured":"Peer Mohamed B, Goadsby PJ, Prabhakar P (2012) Safety and efficacy of flunarizine in childhood migraine: 11\u00a0years\u2019 experience, with emphasis on its effect in hemiplegic migraine. Dev Med Child Neurol 54:274\u2013277. doi: 10.1111\/j.1469-8749.2011.04154.x","journal-title":"Dev Med Child Neurol"},{"key":"2786_CR39","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1517\/14656566.9.15.2565","volume":"9","author":"S Evers","year":"2008","unstructured":"Evers S (2008) Treatment of migraine with prophylactic drugs. Expert Opin Pharmacother 9:2565\u20132573. doi: 10.1517\/14656566.9.15.2565","journal-title":"Expert Opin Pharmacother"},{"key":"2786_CR40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neulet.2010.10.064","volume":"487","author":"Q Ye","year":"2011","unstructured":"Ye Q, Yan L-Y, Xue L-J et al (2011) Flunarizine blocks voltage-gated Na(+) and Ca(2+) currents in cultured rat cortical neurons: a possible locus of action in the prevention of migraine. Neurosci Lett 487:394\u2013399. doi: 10.1016\/j.neulet.2010.10.064","journal-title":"Neurosci Lett"},{"key":"2786_CR41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10194-011-0300-1","volume":"12","author":"F Li","year":"2011","unstructured":"Li F, Qiu E, Dong Z et al (2011) Protection of flunarizine on cerebral mitochondria injury induced by cortical spreading depression under hypoxic conditions. J Headache Pain 12:47\u201353. doi: 10.1007\/s10194-011-0300-1","journal-title":"J Headache Pain"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-013-2786-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-013-2786-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-013-2786-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T14:04:47Z","timestamp":1646921087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-013-2786-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,29]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["2786"],"URL":"https:\/\/doi.org\/10.1007\/s00405-013-2786-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718157033.793486792","asserted-by":"object"}]},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,29]]}}}